Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Soo-Jeong Cho"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer
Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Myeong-Cherl Kook, Keun Won Ryu, Young-Woo Kim, Il Ju Choi
Cancer Res Treat. 2016;48(3):1020-1029.   Published online November 17, 2015
DOI: https://doi.org/10.4143/crt.2015.264
AbstractAbstract PDFPubReaderePub
Purpose
Negative Helicobacter pylori status has been identified as a poor prognostic factor for survival in gastric cancer (GC) patients who underwent surgery. The aim of this study was to examine the effect of H. pylori eradication on long-term outcomes after distal gastrectomy for GC.
Materials and Methods
We analyzed the survival of 169 distal GC patients enrolled in a prospective randomized trial evaluating histologic changes of gastric mucosa after H. pylori eradication in the remnant stomach. The outcomes measured were overall survival (OS) and GC recurrence rates.
Results
The median follow-up duration was 9.4 years. In the modified intention-to-treat analysis including patients who underwent H. pylori treatment (n=87) or placebo (n=82), 5-year OS rates were 98.9% in the treatment group and 91.5% in the placebo group, and KaplanMeier analysis showed no significant difference in OS (p=0.957) between groups. In multivariate analysis, no difference in overall mortality was observed between groups (adjusted hazard ratio [aHR] for H. pylori treatment, 0.75; p=0.495) or H. pylori-eradicated status (aHR for positive H. pylori status, 1.16; p=0.715), while old age, male sex, and advanced stage ≥ IIIa were independent risk factors. Six patients in the treatment group (6.9%) and seven patients in the placebo group (8.5%) had GC recurrences, and GC recurrence rates were not different according to H. pylori treatment (5-year GC recurrence rates, 4.6% in the treatment group vs. 8.5% in the placebo group; p=0.652).
Conclusion
H. pylori eradication for GC patients who underwent distal gastrectomy did not compromise long-term survival after surgery.

Citations

Citations to this article as recorded by  
  • Relationship between Helicobacter pylori infection and programmed death-ligand 1 in gastric cancer: A meta-analysis
    Hong-Chang Yang, Cheng-Feng Fu, Li-Jun Qiao, Gen-He Long, Li-Fen Yang, Biao Yao
    World Journal of Clinical Oncology.2025;[Epub]     CrossRef
  • The relationship between the eradication of Helicobacter pylori and the occurrence of stomach cancer: an updated meta-analysis and systemic review
    Zhouhan Wu, Yi Tang, Meiwen Tang, Zhoutong Wu, Yonghui Xu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Anti–Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy
    Zhoukai Zhao, Ruopeng Zhang, Guoming Chen, Man Nie, Feiyang Zhang, Xiaojiang Chen, Jun Lin, Zewei Chen, Feizhi Lin, Chengzhi Wei, Ziqi Zheng, Shenghang Ruan, Bowen Huang, Yingbo Chen, Runcong Nie
    JAMA Network Open.2024; 7(3): e243812.     CrossRef
  • Helicobacter Pylori and Celiac Disease Antibody Positivity Have a Higher Prevalence in Patients With Distal Gastrectomy: A Cross-Sectional Retrospective Study
    Kubilay Issever, Ersin Kuloglu, Demet Sengul, Ali Muhtaroglu, Ahmet Cumhur Dulger
    Cureus.2023;[Epub]     CrossRef
  • The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single‐center prospective study
    Senichiro Yanagawa, Nobuaki Fujikuni, Kazuaki Tanabe, Masahiro Nakahara, Toshio Noriyuki
    Cancer Reports.2023;[Epub]     CrossRef
  • Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis
    Zhifang Jia, Min Zheng, Jing Jiang, Donghui Cao, Yanhua Wu, Yuzheng Zhang, Yingli Fu, Xueyuan Cao
    BMC Cancer.2022;[Epub]     CrossRef
  • Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi
    Journal of Gastroenterology.2022; 57(7): 464.     CrossRef
  • Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
    Young-Il Kim, Il Ju Choi
    Journal of Gastric Cancer.2022; 22(3): 169.     CrossRef
  • Helicobacter Pylori and Gastric Cancer Progression
    Marina A. Senchukova
    Current Microbiology.2022;[Epub]     CrossRef
  • Identifying Factors Affecting Cancer-related Death in Patients with Adenocarcinoma Gastric Cancer; An Analysis in the Presence of Competing Risks
    Malihe Safari, Hossein Mahjub, Habib Esmaeili, Mohamad Abasi, Ghodratollah Roshanaei
    International Journal of Cancer Management.2021;[Epub]     CrossRef
  • T stage and venous invasion are crucial prognostic factors for long-term survival of patients with remnant gastric cancer: a cohort study
    Kentaro Matsuo, Sang-Woong Lee, Ryo Tanaka, Yoshiro Imai, Kotaro Honda, Kohei Taniguchi, Hideki Tomiyama, Kazuhisa Uchiyama
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Tracking the Virulent Helicobacter pylori Strains Instead of Its Pan-Screening to Prevent Gastric Cancer
    Farid Rahimi, Amin Talebi Bezmin Abadi
    BioNanoScience.2020; 10(1): 315.     CrossRef
  • Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis
    Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang
    Microbial Pathogenesis.2020; 142: 104075.     CrossRef
  • Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years
    Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sang-Hoon Ahn, Do Joong Park, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim
    Gastric Cancer.2020; 23(6): 1051.     CrossRef
  • Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study
    Hyun Ju Kim, Yun Jin Kim, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
    Gastrointestinal Endoscopy.2020; 92(3): 613.     CrossRef
  • Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy
    Youn I Choi, Jun-Won Chung
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(3): 204.     CrossRef
  • Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP)
    Minoosh Moghimi, Yousef Mortazavi, Saeed Razavi-Dizaji, Shahrbanoo Keyhanian, Zahra Ghadimi, Sahar Baba Ali, Saeideh Mazloomzadeh, Sattar Jafari, Reza Mansouri, Masoud Asadi-Khiavi
    Journal of Advances in Medical and Biomedical Research.2019; 27(124): 1.     CrossRef
  • Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
    Il Ju Choi, Myeong-Cherl Kook, Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Byung-Ho Nam
    New England Journal of Medicine.2018; 378(12): 1085.     CrossRef
  • Helicobacter pyloriEradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
    Bum Jun Kim, Hyeong Su Kim, Hyun Joo Jang, Jung Han Kim
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • Do We Need to Retest of Helicobacter pylori Infection after Gastric Cancer Surgery?
    Sang Kil Lee
    Gut and Liver.2017; 11(2): 169.     CrossRef
  • 12,414 View
  • 203 Download
  • 18 Web of Science
  • 20 Crossref
Close layer
Effects of Polymorphisms of Innate Immunity Genes and Environmental Factors on the Risk of Noncardia Gastric Cancer
Jeongseon Kim, Young Ae Cho, Il Ju Choi, Yeon-Su Lee, Sook-Young Kim, Jung-Ah Hwang, Soo-Jeong Cho, Myeong-Cherl Kook, Chan Gyoo Kim, Young-Woo Kim
Cancer Res Treat. 2013;45(4):313-324.   Published online December 31, 2013
DOI: https://doi.org/10.4143/crt.2013.45.4.313
AbstractAbstract PDFPubReaderePub
PURPOSE
Increasing evidence suggests that polymorphisms in innate immunity genes are associated with Helicobacter pylori-induced inflammation and may influence susceptibility in developing noncardia gastric cancer. Therefore, we investigate the effect of polymorphisms of innate immunity genes and interactions with environmental factors in the Korean population.
MATERIALS AND METHODS
We genotyped four polymorphisms of TLR2 (rs1898830), TLR4 (rs10983755 and rs10759932), and CD14 (rs2569190) in a case-control study of 487 noncardia gastric cancer patients and 487 sex- and age-matched healthy controls. Polytomous logistic regression models were used to detect the effects of genetic polymorphisms and environmental factors, which were stratified by the histological type of gastric cancer.
RESULTS
TLR4 rs10983755 A carriers were found to have higher risk of intestinal-type noncarida gastric cancer than G homozygotes (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.01 to 1.97), but other genetic variants showed no association with the risk of noncardia gastric cancer. Among H. pylori-positive participants, smokers carrying TLR4 rs10983755 A had a higher risk of intestinal-type gastric cancer than nonsmoking TLR4 rs10983755 G homozygotes (OR, 4.28; 95% CI, 2.12 to 8.64). In addition, compared with tap water, other drinking water sources during childhood were found to be associated with the elevated risk of intestinal-type gastric cancer, and these associations were slightly stronger among TLR4 rs10983755 A carriers.
CONCLUSION
The genetic polymorphisms of innate immunity genes are associated with the development of intestinal-type noncardia gastric cancer and these associations may differ in accordance to an exposure to certain environmental factors.

Citations

Citations to this article as recorded by  
  • Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer
    Rabeb M. Ghali, Sonia Zaied, Amira Daldoul, Perizat Kanabekova, Wassim Y. Almawi
    Gene.2024; 928: 148773.     CrossRef
  • Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
    Eglė Žilienė, Arturas Inčiūra, Rasa Ugenskienė, Elona Juozaitytė
    Diagnostics.2023; 13(12): 1999.     CrossRef
  • Ranking and Prioritizing Risk Factors for Gastric Cancer
    Ali Reza Yusefi, Shima Bordbar, Gholamhossein Mehralian, Kamran Bagheri Lankarani, Mohammad Khammarnia, Zahra Kavosi, Peivand Bastani
    The Open Public Health Journal.2023;[Epub]     CrossRef
  • Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis
    Ayoub Al Othaim, Sulieman Ibraheem Shelash Al-Hawary, Hashem O. Alsaab, Sami G. Almalki, Mazin A. A. Najm, Ahmed Hjazi, Ali Alsalamy, Abbas Firras Almulla, Hamzeh Alizadeh
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer
    Xu Han, Tianyu Liu, Jiabao Zhai, Chang Liu, Wanyu Wang, Chuang Nie, Qi Wang, Xiaojie Zhu, Haibo Zhou, Wenjing Tian
    PeerJ.2022; 10: e13774.     CrossRef
  • Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate
    Debashis Dutta, Moumita Majumder, Ramesh Kumar Paidi, Kalipada Pahan
    Neurobiology of Disease.2021; 153: 105318.     CrossRef
  • Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice
    Donghui Cao, Zhifang Jia, Yanhua Wu, Tongrong Su, Dan Zhao, Menghui Wu, Tetsuya Tsukamoto, Masanobu Oshima, Jing Jiang, Xueyuan Cao
    Life Sciences.2020; 263: 118580.     CrossRef
  • Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract
    Evagelia Spanou, Polyxeni Kalisperati, Ioannis S. Pateras, Alexandros Papalampros, Alexandra Barbouti, Athanasios G. Tzioufas, Athanassios Kotsinas, Stavros Sougioultzis
    Frontiers in Genetics.2017;[Epub]     CrossRef
  • Increased deaths from gastric cancer in communities living close to waste landfills
    Agostino Di Ciaula
    International Journal of Environmental Health Research.2016; 26(3): 281.     CrossRef
  • Correlation of Serum Levels of Endostatin with Tumor Stage in Gastric Cancer: A Systematic Review and Meta-Analysis
    Zheng-Hua Wang, Zhi-Tu Zhu, Xu-Yang Xiao, Jin Sun
    BioMed Research International.2015; 2015: 1.     CrossRef
  • Pattern-Recognition Receptors and Gastric Cancer
    Natalia Castaño-Rodríguez, Nadeem O. Kaakoush, Hazel M. Mitchell
    Frontiers in Immunology.2014;[Epub]     CrossRef
  • 12,618 View
  • 62 Download
  • 11 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP